Heribert Bieling
University of Bonn
14 Papers
600 Citations
Heribert Bieling is an academic researcher from University of Bonn. The author has contributed to research in topics: Breast cancer & Breast MRI. The author has an hindex of 10, co-authored 14 publications.
Chat about Author
Papers
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study
Christiane K. Kuhl,Simone Schrading,Heribert Bieling,Eva Wardelmann,Claudia Leutner,Roy Koenig,Walther Kuhn,Hans H. Schild +7 more
TL;DR: Investigating the sensitivity with which ductal carcinoma in situ (DCIS) is diagnosed by mammography and by breast MRI found MRI could help improve the ability to diagnose DCIS, especially DCIS with high nuclear grade.
730
Abbreviated Breast Magnetic Resonance Imaging (MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection—A Novel Approach to Breast Cancer Screening With MRI
Christiane K. Kuhl,Simone Schrading,Kevin Strobel,Hans H. Schild,Ralf-Dieter Hilgers,Heribert Bieling +5 more
TL;DR: An MRI acquisitionTime of 3 minutes and an expert radiologist MIP image reading time of 3 seconds are sufficient to establish the absence of breast cancer, with an NPV of 99.8%.
615
•Journal Article
MRI for diagnosis of pure ductal carcinoma in situ : a prospective observational study. Commentary
Carla Boetes,Ritse M. Mann,Christione K. Kuhl,Simone Schrading,Heribert Bieling,Eva Wardelmann,Claudia Leutner,Roy Koenig,Walther Kuhn,Hans H. Schild +9 more
TL;DR: In this article, the authors investigated the sensitivity with which ductal carcinoma in situ (DCIS) is diagnosed by mammography and by breast MRI and compared the biological profiles of mammography-diagnosed DCIS versus DCIS detected by MRI alone.
560
Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial
Christiane K. Kuhl,Stefanie Weigel,Simone Schrading,Birke Arand,Heribert Bieling,Roy König,Bernd Tombach,Claudia Leutner,Andrea Rieber-Brambs,Dennis Nordhoff,Walter Heindel,Maximilian F. Reiser,Hans H. Schild +12 more
TL;DR: In women at elevated familial risk, quality-assured MRI screening shifts the distribution of screen-detected breast cancers toward the preinvasive stage and neither mammography, nor annual or half-yearly ultrasound or CBE will add to the cancer yield achieved by MRI alone.
506
Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer
Christiane K. Kuhl,Kevin Strobel,Heribert Bieling,Claudia Leutner,Hans H. Schild,Simone Schrading +5 more
TL;DR: In women at average risk for breast cancer, MR imaging screening improves early diagnosis of prognostically relevant breast cancer and offers high specificity and positive predictive value of MR Imaging screening.
323